Cyclophilin A and CD147 associate with progression of diabetic nephropathy
Authors:
- 2 December 2018
- journal article
- research article
- Published by Taylor & Francis in Free Radical Research
- Vol. 52 (11-12) , 1456-1463
Abstract
To find the associations of circulating cyclophilin A (CyP A) and CD147/EMMPRIN with renal outcomes in type 2 diabetes patients and possible pathogenesis involved. Total 131 patients were recruited since 2004. Glycated hemoglobin, blood glucose and urine albumin–creatinine ratio levels at baseline and every 3 months were measured. Plasma CyP A and CD147 were also measured at baseline. Patients were divided into two groups based upon the median level of the baseline plasma CyP A value: < 93.64 ng/mL (group A, n = 65), ≥ 93.64 ng/mL (group B, n = 66). The estimated glomerular filtration rate was calculated at each follow-up visit. Besides, mitochondrial function assay by cellular mitochondrial energy utility was studied when cells were exposed to glucose or exogenous CyP A or both. Multivariate analysis, using median level (93.64) ng/mL as the cut-off value, revealed that circulating CyP A and CD147 levels at baseline were associated with the baseline estimated glomerular filtration rate (eGFR) (p = .042 and p = .001 separately) in cross-sectional analysis. Longitudinally, higher baseline plasma CyP A level was also correlated to a rapid decline in eGFR (p = .016). The results were also significant when using the continuous plasma CyP A level (p = .003). In cells exposed to glucose, results of oxygen consumption rate (OCR) showed a significant reduction in basal respiration, maximal respiration and ATP production. Depressed OCR further occurred when incubated with both of CyP A and glucose. Plasma CyP A and CD147 can serve as indicators of renal disease progression in type 2 diabetes patients.Keywords
This publication has 34 references indexed in Scilit:
- Urinary Cyclophilin A as a New Marker for Diabetic NephropathyMedicine, 2015
- Cyclophilin A in Cardiovascular Homeostasis and DiseasesThe Tohoku Journal of Experimental Medicine, 2015
- CD147 (EMMPRIN/Basigin) in kidney diseases: from an inflammation and immune system viewpointNephrology Dialysis Transplantation, 2014
- Early Change in Proteinuria as a Surrogate End Point for Kidney Disease Progression: An Individual Patient Meta-analysisAmerican Journal of Kidney Diseases, 2014
- Albuminuria and Kidney Function Independently Predict Cardiovascular and Renal Outcomes in DiabetesJournal of the American Society of Nephrology, 2009
- Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritisRheumatology, 2008
- Predicting initiation and progression of chronic kidney disease: Developing renal risk scoresKidney International, 2006
- Roles of Cyclophilins in Cancers and Other Organ SystemsWorld Journal of Surgery, 2005
- Elevated Serum Cyclophilin Levels in Patients with Severe SepsisJournal of Clinical Immunology, 1997
- [57] Determination of the production of superoxide radicals and hydrogen peroxide in mitochondria1984